A case report of endorectal displacement of a right ureteral stent following radiochemotherapy and Bevacizumab

The angiogenesis inhibitor monoclonal antibody Bevacizumab is presently the standard treatment for numerous neoplasms but particular toxicities are emerging, such as hypertension, haemorrhage, thromboembolism,...
Source: BMC Urology - Category: Urology & Nephrology Authors: Tags: Case report Source Type: research